ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,658
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Combination of Venetoclax, Azacytidine and Ivosidenib in IDH1 Mutated AML
Author(s):
C Dinardo
Publication date:
2020
Journal:
Abstr. EHA
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ScienceOpen Research
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
2,658
Ivosidenib Improves Overall Survival Relative to Standard Therapies in Relapsed or Refractory Mutant IDH1 AML: Results from Matched Comparisons to Historical Controls
Authors:
P Paschka
,
H Dombret
,
X. Thomas
…
ClarIDHy: A Global, Phase 3, Randomized, Double-Blind Study of Ivosidenib (IVO) vs. Placebo in Patients with Advanced Cholangiocarcinoma (CC) with a … | OncologyPRO
Authors:
G.K. Abou-Alfa
,
T. Macarulla Mercade
,
M Javle
…
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors
Authors:
Raphael Reinbold
,
Ingvild C. Hvinden
,
Patrick Rabe
…
See all similar
Cited by
1
Descriptive and Functional Genomics in Acute Myeloid Leukemia (AML): Paving the Road for a Cure
Authors:
Hélène Pasquer
,
Maëlys Tostain
,
Nina Kaci
…
See all cited by